What Is CDSCO Audit Readiness?
Understanding CDSCO Audit Readiness
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory authority for pharmaceuticals and medical devices, operating under the Ministry of Health and Family Welfare. It governs drug approvals, manufacturing standards, import licensing, and post-market surveillance. Inspections can be triggered by product complaints, safety signals from the market, or scheduled site audits. For pharmaceutical manufacturers operating in or exporting from India, CDSCO compliance is a legal requirement.
Audit readiness means more than having paperwork on file. It means every stakeholder in the supply chain — manufacturer, clearing and forwarding agent, stockist, and retailer — operates within a documented and verifiable system. Inspectors can request batch records, distribution logs, recall procedures, and chain-of-custody evidence within the audit window. Brands that rely on spreadsheets and courier records to reconstruct this data typically cannot meet that expectation under time pressure.
Key Components of CDSCO Audit Readiness
Why CDSCO Audit Readiness Matters
Failing a CDSCO inspection carries significant consequences: product recalls, manufacturing suspension, import licence cancellation, and reputational damage that affects domestic and export market access. Beyond regulatory risk, the absence of a documented supply chain makes it impossible to contain a quality event quickly. A single batch problem can escalate into a multi-market issue before it is identified and contained.
- Reduces time-to-contain in a product recall from days to hours
- Provides documented evidence of GDP compliance during inspections
- Identifies counterfeit or diverted product entering the authorised supply chain
- Supports WHO prequalification requirements for export market access
- Strengthens post-market surveillance reporting for adverse event investigations
How Acviss Supports CDSCO Compliance
Acviss's Origin supply chain traceability platform gives pharmaceutical manufacturers the infrastructure required to achieve and maintain CDSCO audit readiness. Origin assigns a unique, blockchain-backed digital identity to every product unit, records each supply chain event from manufacturing to point of sale, and aggregates the full audit trail in a dashboard accessible to quality and compliance teams at any time.
For unit-level product authentication, Certify adds a non-cloneable identifier to each pack. Distributors and pharmacists can verify product authenticity via a WhatsApp scan with no app download required, making last-mile compliance practical even in low-connectivity markets. Together, Origin and Certify provide the documentation, supply chain visibility, and authentication capability required to prepare for and pass a CDSCO inspection.
See how Acviss supports CDSCO compliance
Acviss has deployed supply chain traceability and product authentication for pharmaceutical brands across India, Africa, and Southeast Asia. Book a walkthrough to see how Origin and Certify can be configured for your manufacturing and distribution setup.
Book a Free DemoFrequently Asked Questions
The Central Drugs Standard Control Organisation (CDSCO) is India's apex regulatory body for pharmaceuticals and medical devices. It has authority to approve new drugs, licence manufacturing sites, regulate imports and exports, and conduct post-market inspections. Non-compliance can result in product recall, manufacturing licence suspension, or import ban. For brands selling in India or exporting from Indian manufacturing facilities, CDSCO requirements are mandatory.
Auditors typically examine batch manufacturing records, storage and distribution logs, deviation and complaint reports, recall procedure documentation, and evidence that Good Distribution Practice guidelines are followed across the distribution chain. Serialisation records showing unit-level traceability are increasingly expected, particularly for Schedule H and Schedule H1 drugs. Quality teams should be able to produce the complete chain of custody for any specific batch within the audit window.
Track and trace systems like Acviss Origin automatically record every supply chain event — manufacturing, dispatch, receipt, and return — creating a timestamped, tamper-evident audit trail. During an inspection, quality teams retrieve the complete distribution history for any batch from the dashboard rather than compiling it manually from spreadsheets and courier records.
For most regulated categories, yes. Batch-level traceability is the minimum requirement, but unit-level serialisation is required for Schedule H and H1 drugs, and is best practice for any product at risk of diversion or counterfeiting. Unit-level data makes recall management significantly more precise — allowing brands to isolate affected packs rather than withdrawing entire batches from a distribution territory.
Yes. Origin supports integration with SAP and Microsoft Dynamics 365. Acviss can layer on top of existing batch data to add consumer-facing authentication, distributor scan events, and dashboard reporting without replacing the ERP configuration. Integration scope depends on your current system architecture — book a call to discuss your setup.
